Diagnostic accuracy of the GenoType MTBDRsl assay for rapid diagnosis of extensively drug-resistant tuberculosis in HIV-coinfected patients

Journal of Clinical Microbiology

Volumn 51, Issue 1, 2013, Pages 243-248

  Kontsevaya, Irina ^a   Ignatyeva, Olga ^a   Nikolayevskyy, Vladyslav ^b   Balabanova, Yanina ^b   Kovalyov, Alexander ^a   Kritsky, Andrey ^a   Matskevich, Olesya ^a   Drobniewski, Francis ^b,c  

^a Samara Oblast Tuberculosis Dispensary   (Russian Federation)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CAPREOMYCIN; CYCLOPEPTIDE; ETHAMBUTOL; KANAMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM DETECTION; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FEMALE; GENOTYPE MTBDRSL ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; RUSSIAN FEDERATION; SENSITIVITY AND SPECIFICITY; SPUTUM ANALYSIS; SPUTUM SMEAR;

ADULT; BACTERIOLOGICAL TECHNIQUES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; FEMALE; GENOTYPE; HIV INFECTIONS; HUMANS; MALE; MASS SCREENING; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOBACTERIUM TUBERCULOSIS; SENSITIVITY AND SPECIFICITY;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84871691515     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02513-12     Document Type: Article

References (28)

1. World Health Organization. 2011. Global tuberculosis control: WHO report. World Health Organization, Geneva, Switzerland.
2. Raviglione MC, Snider DE, Jr, Kochi A. 1995. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 273:220-226.
3. World Health Organization. 2012.WHOpolicy on collaborative TB/HIV activities. Guidelines for national programmes. Report no. WHO/HTM/HIV/2004.1. World Health Organization, Geneva, Switzerland.
4. Balabanova Y, Nikolayevskyy V, Ignatyeva O, Kontsevaya I, Rutterford CM, Shakhmistova A, Malomanova N, Chinkova Y, Mironova S, Fedorin I, Drobniewski FA. 2011. Survival of civilian and prisoner drugsensitive, multi- and extensive drug-resistant tuberculosis cohorts prospectively followed in Russia. PLoS One 6 : e20531. doi:10.1371/journal.pone.0020531.
5. Balabanova Y, Radiulyte B, Davidaviciene E, Hooper R, Ignatyeva O, Nikolayevskyy V, Drobniewski FA. 2011. Survival of drug resistant tuberculosis patients in Lithuania: retrospective national cohort study. BMJ Open 1:e000351. doi:10.1136/bmjopen-2011-000351.
6. Wright A, Zignol M, Van Deun A, Falzon D, Gerdes SR, Feldman K, Hoffner S, Drobniewski F, Barrera L, van Soolingen D, Boulabhal F, Paramasivan CN, Kam RM, Mitarai S, Nunn P, Raviglione M. 2009. Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet 373:1861-1873.
7. Punga VV, Jakubowiak WM, Danilova ID, Somova TR, Volchenkov GV, Kazionnyy BY, Nemtsova ES, Kiryanova EV, Kourbatova EV. 2009. Prevalence of extensively drug-resistant tuberculosis in Vladimir and Orel regions, Russia. Int. J. Tuberc. Lung Dis. 13:1309-1312.
8. Federal Scientific Methodic Center for HIV Fight and Prevention. 2010. VICh-infektsiya: Informatsionny Byulleten [HIV infection: information bulletin]. Federal Scientific Methodic Center for HIV Fight and Prevention, Moscow, Russia.
9. Getahun H, Harrington M, O'Brien R, Nunn P. 2007. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet 369:2042-2049. (Pubitemid 46908825)
10. Mugusi F, Villamor E, Urassa W, Saathoff E, Bosch RJ, Fawzi WW. 2006. HIV co-infection, CD4 cell counts and clinical correlates of bacillary density in pulmonary tuberculosis. Int. J. Tuberc. Lung Dis. 10:663-669. (Pubitemid 43845028)
11. World Health Organization. 2008. Molecular line probe assays for rapid screening of patients at risk of multidrug resistant tuberculosis (MDRTB): policy statement. World Health Organization, Geneva, Switzerland.
12. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, Zeller K, Andrews J, Friedland G. 2006. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368:1575-1580. (Pubitemid 44780738)
13. Hillemann D, Rusch-Gerdes S, Richter E. 2009. Feasibility of the Geno-Type MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens. J. Clin. Microbiol. 47:1767-1772.
14. Brossier F, Veziris N, Aubry A, Jarlier V, Sougakoff W. 2010. Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates. J. Clin. Microbiol. 48:1683-1689.
15. Miotto P, Cabibbe AM, Mantegani P, Borroni E, Fattorini L, Tortoli E, Migliori GB, Cirillo DM. 2012. GenoType MTBDRsl performance on clinical samples with diverse genetic background. Eur. Respir. J. 40:690-698.
16. Ignatyeva O, Kontsevaya I, Kovalyov A, Balabanova Y, Nikolayevskyy V, Toit K, Dragan A, Maxim D, Mironova S, Kummik T, Muntean I, Koshkarova E, Drobniewski F. 2012. Detection of resistance to secondline antituberculosis drugs by use of the genotype MTBDRsl assay: a multicenter evaluation and feasibility study. J. Clin. Microbiol. 50:1593-1597.
17. Theron G, Peter J, van Zyl-Smit R, Mishra H, Streicher E, Murray S, Dawson R, Whitelaw A, Hoelscher M, Sharma S, Pai M, Warren R, Dheda K. 2011. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am. J. Respir. Crit. Care Med. 184:132-140.
18. Scott LE, McCarthy K, Gous N, Nduna M, Van Rie A, Sanne I, Venter WF, Duse A, Stevens W. 2011. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study. PLoS Med. 8:e1001061. doi:10.1371/journal.pmed. 1001061.
19. Bossuyt PM, Reitsma JB. 2003. The STARD initiative. Lancet 361:71. doi:10.1016/S0140-6736(03)12122-8.
20. Siddiqi S, Rusch-Gerdes S. 2006. MGIT procedure manual for BACTEC MGIT 960 TB system (also applicable for manual MGIT). Becton, Dickinson, Franklin Lakes, NJ.
21. Lacoma A, Garcia-Sierra N, Prat C, Maldonado J, Ruiz-Manzano J, Haba L, Gavin P, Samper S, Ausina V, Dominguez J. 2012. GenoType MTBDRsl for molecular detection of second-line-drug and ethambutol resistance in Mycobacterium tuberculosis strains and clinical samples. J. Clin. Microbiol. 50:30-36.
22. Said HM, Kock MM, Ismail NA, Baba K, Omar SV, Osman AG, Hoosen AA, Ehlers MM. 2012. Evaluation of the GenoType(R) MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs. Int. J. Tuberc. Lung Dis. 16:104-109.
23. Huang WL, Chi TL, Wu MH, Jou R. 2011. Performance assessment of the GenoType MTBDRsl test and DNA sequencing for detection of second-line and ethambutol drug resistance among patients infected with multidrug-resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 49:2502-2508.
24. Casali N, Nikolayevskyy V, Balabanova Y, Ignatyeva O, Kontsevaya I, Harris SR, Bentley SD, Parkhill J, Nejentsev S, Hoffner SE, Horstmann RD, Brown T, Drobniewski F. 2012. Microevolution of extensively drug-resistant tuberculosis in Russia. Genome Res. 22:735-745.
25. Gikalo MB, Nosova EY, Krylova LY, Moroz AM. 2012. The role of eis mutations in the development of kanamycin resistance in Mycobacterium tuberculosis isolates from the Moscow region. J. Antimicrob. Chemother. 67:2107-2109.
26. Nodieva A, Jansone I, Broka L, Pole I, Skenders G, Baumanis V. 2010. Recent nosocomial transmission and genotypes of multidrug-resistant Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 14:427-433.
27. Pardini M, Niemann S, Varaine F, Iona E, Meacci F, Orru G, Yesilkaya H, Jarosz T, Andrew P, Barer M, Checchi F, Rinder H, Orefici G, Rusch-Gerdes S, Fattorini L, Oggioni MR, Bonnet M. 2009. Characteristics of drug-resistant tuberculosis in Abkhazia (Georgia), a highprevalence area in Eastern Europe. Tuberculosis (Edinb.) 89:317-324.
28. Devaux I, Kremer K, Heersma H, Van Soolingen D. 2009. Clusters of multidrug-resistant Mycobacterium tuberculosis cases, Europe. Emerg. Infect. Dis. 15:1052-1060.